Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-13 Purchase |
2021-05-17 09:22 am |
Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director |
2,466,666 | $1.35 | $3,329,999 | 4,827,129 (Indirect) |
View |
| 2021-05-13 Purchase |
2021-05-17 07:03 am |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (China) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner |
5,925,925 | $1.35 | $7,999,999 | 616,592 (Indirect) |
View |
| 2021-05-13 Purchase |
2021-05-17 07:02 am |
Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director |
5,925,925 | $1.35 | $7,999,999 | 7,804,778 (Indirect) |
View |
| 2021-05-13 Purchase |
2021-05-17 07:00 am |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
5,925,925 | $1.35 | $7,999,999 | 7,804,778 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-19 Option Award |
2021-05-20 4:10 pm |
N/A 2031-05-19 |
Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:10 pm |
N/A 2031-05-19 |
Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-18 5:48 pm |
N/A 2031-04-01 |
Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D |
496,204 | $0 | 496,204 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-18 5:45 pm |
N/A 2031-04-01 |
Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit PRESIDENT AND CEO |
992,409 | $0 | 992,409 (Direct) |
View |
| 2021-04-30 Exercise |
2021-05-03 10:15 am |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
1,562 | $0 | 38,118 (Direct) |
View |
| 2021-04-30 Tax Withholding |
2021-05-03 10:15 am |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
459 | $2.18 | 38,118 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 11:55 am |
N/A 2026-04-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Geffken Daniel E. CHIEF FINANCIAL OFFICER |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:33 pm |
N/A 2031-04-01 |
Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director |
2,572,270 | $0 | 2,485,239 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 9:04 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director |
77,695 | $0 | 77,695 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 9:00 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D |
930,945 | $0 | 1,105,588 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 8:55 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit PRESIDENT AND CEO |
1,702,396 | $0 | 1,925,700 (Direct) |
View |
Ownership |
2021-03-26 8:50 pm |
N/A 2030-01-21 |
Eloxx Pharmaceuticals Inc. | ELOX | Rakers Gary D. Controller, PFO/PAO, Treasurer |
0 | $0 | 42,225 (Direct) |
View |
| 2021-02-25 Tax Withholding |
2021-02-26 7:05 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
7,338 | $3.95 | 101,077 (Direct) |
View |
| 2021-02-25 Exercise |
2021-02-26 7:05 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
25,000 | $0 | 101,077 (Direct) |
View |
| 2021-02-25 Tax Withholding |
2021-02-26 7:05 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
15,360 | $3.95 | 194,629 (Direct) |
View |
| 2021-02-25 Exercise |
2021-02-26 7:05 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
50,000 | $0 | 194,629 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 6:43 pm |
N/A 2031-02-12 |
Eloxx Pharmaceuticals Inc. | ELOX | MacDonald Stephen G. VP FINANCE & ACCTG, TREASURER |
18,849 | $0 | 18,849 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 6:40 pm |
N/A 2031-02-12 |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 6:38 pm |
N/A 2031-02-12 |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-01-30 Exercise |
2021-02-02 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
1,563 | $0 | 20,915 (Direct) |
View |
| 2021-01-30 Tax Withholding |
2021-02-02 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
542 | $3.44 | 20,915 (Direct) |
View |
| 2021-01-30 Exercise |
2021-02-02 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
1,875 | $0 | 24,989 (Direct) |
View |
| 2021-01-30 Tax Withholding |
2021-02-02 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
643 | $3.44 | 24,989 (Direct) |
View |
| 2020-10-30 Tax Withholding |
2020-11-02 4:20 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
625 | $2.53 | 25,632 (Direct) |
View |
| 2020-10-30 Exercise |
2020-11-02 4:20 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
1,875 | $0 | 25,632 (Direct) |
View |
| 2020-10-30 Tax Withholding |
2020-11-02 4:20 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
459 | $2.53 | 21,457 (Direct) |
View |
| 2020-10-30 Exercise |
2020-11-02 4:20 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
1,562 | $0 | 21,457 (Direct) |
View |
| 2020-07-30 Tax Withholding |
2020-07-31 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
459 | $2.84 | 21,916 (Direct) |
View |
| 2020-07-30 Exercise |
2020-07-31 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
1,563 | $0 | 21,916 (Direct) |
View |
| 2020-07-30 Tax Withholding |
2020-07-31 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
576 | $2.84 | 26,257 (Direct) |
View |
| 2020-07-30 Exercise |
2020-07-31 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
1,875 | $0 | 26,257 (Direct) |
View |